Research Article
The Effects of RBP4 and Vitamin D on the Proliferation and Migration of Vascular Smooth Muscle Cells via the JAK2/STAT3 Signaling Pathway
Table 2
Biochemical parameters of rats in different groups.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
a vs. the NC group, b vs. the DM group, c vs. the DAS group, d vs. the VDAS-1 group, and e vs. VDAS-2 group. NC: control group; DM: diabetes without macrovascular disease group; DAS: diabetic atherosclerosis group; VDAS-1: Diabetic atherosclerosis group treated with vitamin D 0.075 μg kg-1 d-1; VDAS-2: diabetic atherosclerosis group treated with vitamin D 0.15 μg kg-1μd-1; VDAS-3: diabetic atherosclerosis group treated with vitamin D 0.3 μg kg-1 d-1; MT: the media thickness of the artery; LD: lumen diameter; LDL-c: low-density lipoprotein cholesterol; TG: triglycerides; TC: total cholesterol; HDL-c: high-density lipoprotein cholesterol; HbA1C: hemoglobin A1c; FPG: fasting plasma glucose; FINS: fasting insulin; RBP4: retinol binding protein 4; HOMA-IR: homeostasis model assessment of insulin resistance; ISI: insulin sensitivity index. |